Skip to content

The effects of body composition on pharmacokinetics of propofol

The effects of body composition on pharmacokinetics of propofol

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004196
Enrollment
100
Registered
2019-08-14
Start date
2019-04-29
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: healty patients, aged 16 to 65 years, who are undergoing orthopedic forearm surgery under brachial plexus block

Exclusion criteria

Exclusion criteria: 1) patient refusal 2) allergy to egg 3) severe renal or hepatic impairment 4) difficulty of communication such as hearing impairment 5) subjects having metal materials implanted 6) subjects with cardiac pacemaker or implantable cardioverter/defibrillator (ICD)

Design outcomes

Primary

MeasureTime frame
correlation coefficient between body fat ratio and effect site concentraion of propofol at loss or consciousness(LOC)

Secondary

MeasureTime frame
correlation coefficient between body fat ratio and total amount of propofol infused to LOC

Countries

Korea, Republic of

Contacts

Public ContactA Ram Doo

Chonbuk National University

ruiwin3518@gmail.com+82-63-250-1241

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026